Skip to main content

Jonathan DiVincenzo

Equibles does not estimate personal net worth.

Get an email with a short summary when Bio-Rad Laboratories, Inc. publishes a filing, an earnings call transcript or a press release.

Get BIO alerts

About Jonathan DiVincenzo

Jonathan DiVincenzo is recorded as COO at Bio-Rad Laboratories, Inc. (BIO). The proxy statement of Bio-Rad Laboratories, Inc. reports total compensation of $3,680,772 for Jonathan DiVincenzo in fiscal 2025, including a base salary of $673,208. Disclosed compensation is on record for 2 fiscal years. Jonathan DiVincenzo has spoken on 4 earnings calls across 1 company, most recently for Bio-Rad Laboratories, Inc. on August 4, 2026. Bio-Rad Laboratories, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Bio-Rad Laboratories, Inc. includes Norman Schwartz (CEO, CFO and Board Member), Roop K. Lakkaraju (CFO and Chief Accounting Officer), Roop Lakkaraju (CFO) and 7 others.

Jonathan DiVincenzo on recent calls

“Total company revenue in the second quarter was approximately $651 million, essentially flat as reported, and down 1.9% on a currency-neutral basis compared with the prior year.”
COO, Bio-Rad Second Quarter 2026 Earnings Results Conference Call and Webcast ·
“In the first quarter, our teams executed within a dynamic operating environment. We reported Q1 results within our revenue guidance as we navigated several external pressures, most notably associated with the ongoing conflict in the Middle East.”
COO, Bio-Rad Laboratories, Inc. Q1 FY2026 Earnings Call ·
“We are pleased to share our second quarter 2025 results, which reflect solid execution across the business. Both revenue and operating margin exceeded consensus expectations, underscoring the strength of our portfolio and the discipline of our teams in a challenging and rapidly evolving macroeconomic environment.”
COO, Bio-Rad Laboratories, Inc. Q2 FY2025 Earnings Call ·
“Despite a challenging macro environment with academic market headwinds due to government funding, and global trade disruptions from tariffs, we delivered solid Q1 results, exceeding consensus for both revenue and operating margins.”
COO, Bio-Rad Laboratories, Inc. Q1 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Bio-Rad Laboratories, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Bio-Rad Laboratories, Inc. (BIO) $673,208 $3,680,772
2024 Bio-Rad Laboratories, Inc. (BIO) $204,515 $4,314,185

Recent activity